Samrat Pharmachem opened lower at ₹254.75, compared with its previous close of ₹256.00. In the last trading session on 12 Nov 2026, the stock traded between ₹253.00 and ₹259.00, with an average traded price of ₹253.73. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Samrat Pharmachem is now worth
₹ 10,723.00
Giving a profit of
₹ 723.00 (7.23%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
₹259.00
Day Low
₹253.00
Day Open
₹254.75
Prev Close
₹256.00
Volume
888
Value Traded
₹0.02 Cr
1W Return
-4.48%
1M Return
9.80%
3M Return
5.70%
6M Return
20.39%
1Y Return
-7.08%
Market Cap (₹ Cr.)
79
PE Ratio
-35.80
PB Ratio
1.16
Dividend Yield
0.39%
ROE
-4.86%
ROCE
-2.95%
Book Value (₹)
220.67
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-4.48%
6 Weeks
-
1 Month
9.80%
3 Months
5.70%
9 Months
6.51%
No data available.
Samrat Pharmachem appoints Divyesh J Shah & Associates as auditors
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as statutory auditors. Appointment effective from conclusion of 34th AGM held on September 23, 2026. New auditors will serve for five years until the 39th AGM in 2031. Outgoing auditors M/s Shah & Savla LLP retired after completing ten-year tenure. Change complies with Companies Act, 2013 restrictions on auditor reappointment.
1mo agoSamrat Pharmachem FY26 results: Revenue up 1.4%, EBITDA turns negative
Samrat Pharmachem FY26 revenue rose 1.4% to ₹289.72 crore. EBITDA swung to a loss of ₹3.94 crore from ₹11.87 crore profit in FY25. All four AGM resolutions approved by simple majority via e-voting. Promoters voted unanimously in favor; 35,000 votes cast against by public.
1mo agoSamrat Pharmachem sets Sep 23 for 34th AGM; e-voting begins Sep 20
Samrat Pharmachem holds 34th AGM on September 23, 2026. Remote e-voting window runs from September 20 to 22. Voting rights cut-off date is set for September 16, 2026. Share transfer books closed from September 20 to 22.
2mo agoSamrat Pharmachem Q1 Results: Net profit turns positive at ₹87.6 lakh
Samrat Pharmachem Ltd returned to profitability in Q1FY27 with a net profit of ₹87.60 lakh, reversing a ₹203.63 lakh loss in Q4FY26. Revenue increased 5.4% YoY to ₹7,976.10 lakh. The company had reported a net loss of ₹331.20 lakh for the full FY25.
2mo agoSamrat Pharmachem appoints Divyesh J Shah & Associates as statutory auditors
Samrat Pharmachem Limited has appointed Divyesh J Shah & Associates as its statutory auditors for a five-year term, pending shareholder approval. The Board approved the appointment on July 15, 2026, effective from the conclusion of the 34th Annual General Meeting. The firm, established in 1998, specializes in auditing, taxation, and management consultancy.
3mo agoSamrat Pharmachem Limited Publishes Newspaper Extract of Standalone Audited Financial Results for FY26
Samrat Pharmachem Limited published an extract of its standalone audited financial results for the quarter and year ended March 31, 2026, in the Indian Express (Baroda Edition) and Vadodara Samachar on June 2, 2026. The publication was made pursuant to Regulation 47 of the SEBI LODR Regulations, 2015. An intimation along with copies of the newspaper advertisements was submitted to BSE Limited on June 4, 2026, by Company Secretary and Compliance Officer Nishant Kankaria.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,896.40 | +0.60% | ₹4,55,009.88 | 41.20 | +9.49% | |
| ₹11,503.00 | +0.16% | ₹3,05,368.51 | 90.40 | +76.43% | |
| ₹4,686.00 | -0.87% | ₹1,78,240.38 | 85.50 | +22.52% | |
| ₹2,432.80 | +1.37% | ₹1,31,447.16 | 97.10 | +145.92% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.50 | +0.14% | ₹1,15,895.36 | 42.00 | +12.92% | |
| ₹1,408.80 | +0.04% | ₹1,13,811.10 | 39.90 | -7.27% | |
| ₹2,665.50 | +1.02% | ₹1,10,097.17 | 48.10 | +17.42% | |
| ₹1,814.80 | +0.42% | ₹1,04,419.58 | 26.00 | +53.33% | |
| ₹2,019.00 | +0.20% | ₹92,326.85 | 17.60 | -0.73% | |
| ₹2,641.50 | -0.69% | ₹74,549.65 | 51.60 | +42.95% | |
| ₹5,182.50 | -2.25% | ₹61,964.56 | 30.50 | -10.14% |
An investment of ₹10,000 made 5 years ago in Samrat Pharmachem is now worth
₹ 10,723.00
Giving a profit of
₹ 723.00 (7.23%)
Note: Past profits do not guarantee future returns.
